Kamada: Falls after Q4 disappoints

Kamada

10/02/2021 15:30

** U.S.-listed shares of Israel-based drug developer
 KMDA.TA ,  KMDA.O  down 9% at $7.3 
    ** Co posts lower-than-expected Q4 profit, hurt by costs
    ** Co posts revenues of $31.5 mln, below estimates of $32.9
mln
    ** Stock has risen 4% in the last 12 months

 (Reporting by Dania Nadeem in Bengaluru)
 ((Dania.Nadeem@thomsonreuters.com;))